Maraviroc-induced decrease in circulating bacterial products is not linked to an increase in immune activation in HIV-infected individuals.
about
Immune responses during spontaneous control of HIV and AIDS: what is the hope for a cure?Treatment intensification with maraviroc (CCR5 antagonist) leads to declines in CD16-expressing monocytes in cART-suppressed chronic HIV-infected subjects and is associated with improvements in neurocognitive test performance: implications for HIV-aMaraviroc Intensification of cART in Patients with Suboptimal Immunological Recovery: A 48-Week, Placebo-Controlled Randomized TrialMicrobial translocation is correlated with HIV evolution in HIV-HCV co-infected patients.
P2860
Maraviroc-induced decrease in circulating bacterial products is not linked to an increase in immune activation in HIV-infected individuals.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Maraviroc-induced decrease in ...... n in HIV-infected individuals.
@en
Maraviroc-induced decrease in ...... n in HIV-infected individuals.
@nl
type
label
Maraviroc-induced decrease in ...... n in HIV-infected individuals.
@en
Maraviroc-induced decrease in ...... n in HIV-infected individuals.
@nl
prefLabel
Maraviroc-induced decrease in ...... n in HIV-infected individuals.
@en
Maraviroc-induced decrease in ...... n in HIV-infected individuals.
@nl
P2093
P50
P1433
P1476
Maraviroc-induced decrease in ...... n in HIV-infected individuals.
@en
P2093
Brigitte Autran
Christina Psomas
Claudine Barbuat
Jacques Reynes
Jade Ghosn
Jean-Philippe Lavigne
Pierre Corbeau
Selma Trabelsi
P304
P356
10.1182/BLOOD-2013-06-507012
P407
P577
2013-09-01T00:00:00Z